Skip to main content
Log in

Comparison of the effect of homocysteine and its thiolactone on the fibrinolytic system using human plasma and purified plasminogen

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Jakubowski H (2007) The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin Chem Lab Med 12:1704–1716

    Article  Google Scholar 

  2. Karolczak K, Olas B (2009) Mechanism action of homocysteine and its thiolactone in haemostasis system. Physiol Res 58:1–11

    Google Scholar 

  3. Deutch DG, Mertz ET (1970) Plasminogen: purification from human plasma by affinity chromatography. Proc Natl Acad Sci USA 61:636–643

    Google Scholar 

  4. Glowacki R, Wójcik K, Bald E (2001) Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 914:29–35

    Article  CAS  Google Scholar 

  5. Bald E, Chwatko G, Glowacki R et al (2004) Analysis of plasma thiols by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1032:109–115

    Article  CAS  Google Scholar 

  6. Krajewski T, Nowak P, Cierniewski C (1985) Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin. Acta Biochim Pol 32:144–154

    CAS  PubMed  Google Scholar 

  7. Sauls DL, Wolberg AS, Hoffman M (2003) Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia. J Thromb Haemost 1:300–306

    Article  CAS  PubMed  Google Scholar 

  8. Marchi R, Carvajal Z, Weisel JW (2008) Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen. Thromb Haemostasis 99:451–452

    CAS  Google Scholar 

  9. Malinowska J, Nowak P, Olas B. Comparison of the effect of the reduced form homocysteine and its thiolactone on hemostatic properties of plasma and fibrinogen. MCB (submitted)

  10. Sauls DL, Lockhart E, Warren ME et al (2006) Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochem 45:2480–2488

    Article  CAS  Google Scholar 

  11. Sauls DL, Arnold EK, Bell CW et al (2007) Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia. Thromb Res 120:117–126

    Article  CAS  PubMed  Google Scholar 

  12. Jacovina AT, Deora AB, Ling Q et al (2009) Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest 119:3384–3394

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by grant 506/810 from University of Lodz

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beata Olas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kołodziejczyk, J., Malinowska, J., Nowak, P. et al. Comparison of the effect of homocysteine and its thiolactone on the fibrinolytic system using human plasma and purified plasminogen. Mol Cell Biochem 344, 217–220 (2010). https://doi.org/10.1007/s11010-010-0545-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-010-0545-z

Keywords

Navigation